• NovaBridge Biosciences adopted a 2026 Omnibus Share Incentive Plan effective July 13, 2026, replacing its 2020-2025 equity plans for new grants.
• Share pool set at 11,960,000 ordinary shares, equivalent to 5,200,000 American depositary shares, with recycling from forfeitures, cash settlements, or tax withholdings.
• Annual share capacity increases from 2027 through 2036 to the lesser of 3% of prior year-end shares outstanding or a lower board-set amount.
• Awards include options, share appreciation rights, restricted shares, share units, share-based awards, cash-based awards, with terms set by the compensation committee.
• Plan allows accelerated vesting or exercisability on a change in control, subject to award terms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-306688), on July 17, 2026, and is solely responsible for the information contained therein.